Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New propofol formulation avoids hypertriglyceridemia of marketed preparation

Oct. 16, 2001

Selective dopamine D3 receptor antagonists identified by Pharmacia

Oct. 15, 2001

Neuroprotective aminoadamantane derivatives disclosed by Panorama

Oct. 15, 2001

First clinical data for new propofol prodrug presented at ASA meeting

Oct. 15, 2001

Serono confirms submission of Rebif amendment to FDA

Oct. 15, 2001

Dainippon compounds with benzodiazepine receptor subtype selectivity

Oct. 11, 2001

Novel combinations claimed by Merck Frosst for depression and anxiety

Oct. 11, 2001

Novel AEDs validated preclinically available for licensing from ICAgen

Oct. 11, 2001

Orphan Medical submits amended NDA to FDA for Xyrem

Oct. 11, 2001

ICAgen seeks partners for pain management program

Oct. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...